anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

226,081-226,140 of 319,975

filter-aware
43
The table displays clinical trial data for NXC-201, specifically focusing on Cytokine Release Syndrome (CRS) and Immune cell associated Neurotoxicity (ICANS) across three dosage groups.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
44
The table highlights specific adverse events (CRS and ICANS) within a red dashed box.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
45
Highlights NXC-201's lower fludarabine dose (25 mg vs 30 mg) and Carvykti's longer infusion window (5-7 days vs 5 days).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
46
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
47
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
48
The slide uses a bar chart to contrast the combined annual sales of two groups of oncology drugs.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
49
The slide uses three distinct bar charts to compare IMX-110 performance against standard of care or competitor drugs in preclinical mouse models.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
50
Includes a process flow diagram illustrating the mechanism of action of iMX-110 in tumor microenvironments.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
51
Includes survival curves (Kaplan-Meier style), tumor imaging, and median survival metrics.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
52
Includes clinical trial data visualization with PFS (Progression Free Survival) and PD/PR thresholds.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
53
The slide uses a scatter plot to map clinical trials and a table to detail standard-of-care metrics by line of therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
54
The slide compares clinical outcomes for patients across different lines of treatment, emphasizing high disease control and zero drug-related toxicity.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
55
Includes logos for BeiGene and Novartis.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
56
Includes comparative size diagram of IMX-111 vs IgG antibody, bar chart of GLUT1 expression by tissue, box plot of GLUT1 expression by stage, and Kaplan-Meier survival curve.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
57
Includes two sets of charts: tumor volume line charts and survival curves.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
58
Includes multiple citations and diagrams of molecular mechanism and clinical trial results.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
59
The slide compares efficacy data for Humira, Stelara, and Entyvio against their respective placebo groups.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
60
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
61
The slide uses a process-flow style layout to connect platform capabilities to specific product outputs.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
62
The process is presented as a non-linear, snake-like flow (1-5 left-to-right, 6-10 right-to-left).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
63
The slide uses a 3-pillar framework to categorize the platform's foundation, leading to specific product applications.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
64
Includes company logo, tagline, mission statement, date, and ticker symbol.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
01
Slide 1
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
02
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
03
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
04
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
05
The slide uses a combination of a donut chart for composition and a combo bar-line chart for cost trends.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
06
The chart uses a dual-axis approach: left axis for interest rates (percentage), right axis for deposit balances (absolute dollars).Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
07
Includes detailed breakdown of loan origination yields and rate mix (fixed vs variable/indices).Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
08
The slide uses two donut charts to visualize the composition of the portfolio. Data is as of December 31, 2023.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
09
Includes two footnotes regarding exclusions and data adjustments.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Problem1 hit
10
The slide highlights the bank's capital strength and capital allocation priorities.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Solution1 hit
11
Slide 11 of a presentation.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Solution1 hit
12
The slide presents a waterfall-style bridge for NIM changes on the left and a detailed balance sheet/income statement table on the right.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Solution1 hit
13
The slide presents a sensitivity analysis of NII to interest rate shifts, comparing Dec 31 2023 and Sep 30 2023.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
Includes a donut chart for 4Q23 breakdown and a combo bar/line chart for historical trends.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a stacked bar chart for expenses and a standard bar chart for the efficiency ratio to demonstrate cost management.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a before-after framing to compare initial outlooks (as of Jan 2023) with year-end results.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Market Size1 hit
17
The slide uses a before-after framing to compare initial outlooks with year-end results.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Market Size1 hit
18
The slide uses a three-column layout to categorize financial projections.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Market Size1 hit
19
The slide uses a table-like layout to present forward-looking guidance for the fiscal year 2024.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · Market Size1 hit
20
The slide uses a 2x2 grid layout to categorize strategic initiatives.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
21
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
22
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
23
The table contains a likely data entry error in the 6/30/23 column for capital ratios (0.1% for all four metrics).Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
24
Includes 5-year CAGR for select metrics. Data is presented in millions except for per share data.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
25
Includes a table of liquidity sources and a grouped bar chart showing coverage ratios.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
26
Includes FDIC logo and disclaimer at bottom.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
27
The slide uses a mix of donut charts and a bar chart to visualize portfolio composition and risk exposure.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
28
The slide title refers to 'Non-GAAP to GAAP Reconciliation', but the content is a standard financial summary table.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
29
Standard financial disclosure slide for non-GAAP metrics.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
30
The table provides a breakdown of common shareholders' equity and total assets, subtracting goodwill and other intangibles to arrive at tangible measures.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 1 hit
01
Slide 1
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · AttentionLoop · Why Now1 hit
02
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · AttentionLoop · Why Now1 hit
03
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · AttentionLoop · Why Now1 hit
04
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The slide uses a three-column layout to categorize performance metrics.jetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
jetBlue | Results Presentation Deck | 17 slidesjetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
Includes a bar chart for CASM growth and a table for ASM growth, alongside bulleted strategic updates.jetBlue | Results Presentation Deck | 17 slides · JetBlue
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit